<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6982504/results/search/disease/results.xml">
  <result pre=": Case Report: Case Reports An infant with refractory cytomegalovirus‐induced" exact="thrombocytopenia" post="UEMURA et al. UemuraSuguruhttps://orcid.org/0000-0001-7461-91381sgr3u31@yahoo.co.jpMoriTakeshi1NinoNanako1SakakibaraNana1TakafujiSatoru1MyojinShota2TakamiYuichi2MoriokaIchiro3NishimuraNoriyuki1KugoMasaaki2IijimaKazumoto1[1], Department of PediatricsKobe University Graduate"/>
  <result pre="case underscores the importance of considering the association of severe" exact="thrombocytopenia" post="or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV‐induced"/>
  <result pre="importance of considering the association of severe thrombocytopenia or immune" exact="thrombocytopenia" post="with cytomegalovirus (CMV) infection because CMV‐induced thrombocytopenia occasionally requires"/>
  <result pre="association of severe thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV)" exact="infection" post="because CMV‐induced thrombocytopenia occasionally requires antiviral therapy. The present"/>
  <result pre="thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV‐induced" exact="thrombocytopenia" post="occasionally requires antiviral therapy. The present case underscores the"/>
  <result pre="case underscores the importance of considering the association of severe" exact="thrombocytopenia" post="or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV‐induced"/>
  <result pre="importance of considering the association of severe thrombocytopenia or immune" exact="thrombocytopenia" post="with cytomegalovirus (CMV) infection because CMV‐induced thrombocytopenia occasionally requires"/>
  <result pre="association of severe thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV)" exact="infection" post="because CMV‐induced thrombocytopenia occasionally requires antiviral therapy. cytomegalovirus infant"/>
  <result pre="thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV‐induced" exact="thrombocytopenia" post="occasionally requires antiviral therapy. cytomegalovirus infant intravenous immunoglobulin thrombocytopenia"/>
  <result pre="CMV‐induced thrombocytopenia occasionally requires antiviral therapy. cytomegalovirus infant intravenous immunoglobulin" exact="thrombocytopenia" post="fig-count: table-count: page-count: word-count: UemuraS, MoriT, NinoN, et al."/>
  <result pre="Rep. 2020;8:75–78. 10.1002/ccr3.2581 1 BACKGROUND Most cases of cytomegalovirus (CMV)" exact="infection" post="are asymptomatic or self‐limited in immunocompetent patients. However, CMV"/>
  <result pre="infection are asymptomatic or self‐limited in immunocompetent patients. However, CMV" exact="infection" post="occasionally induces severe thrombocytopenia.1, 2, 3, 4, 5, 6"/>
  <result pre="infection occasionally induces severe thrombocytopenia.1, 2, 3, 4, 5, 6" exact="Immune thrombocytopenia" post="(ITP) is an autoimmune disease characterized by isolated thrombocytopenia"/>
  <result pre="occasionally induces severe thrombocytopenia.1, 2, 3, 4, 5, 6 Immune" exact="thrombocytopenia" post="(ITP) is an autoimmune disease characterized by isolated thrombocytopenia"/>
  <result pre="2, 3, 4, 5, 6 Immune thrombocytopenia (ITP) is an" exact="autoimmune" post="disease characterized by isolated thrombocytopenia due to the inhibition"/>
  <result pre="3, 4, 5, 6 Immune thrombocytopenia (ITP) is an autoimmune" exact="disease" post="characterized by isolated thrombocytopenia due to the inhibition of"/>
  <result pre="Immune thrombocytopenia (ITP) is an autoimmune disease characterized by isolated" exact="thrombocytopenia" post="due to the inhibition of platelet production and destruction"/>
  <result pre="remains unknown in most cases, it may be triggered by" exact="viral" post="infections such as by CMV or by other immunological"/>
  <result pre="unknown in most cases, it may be triggered by viral" exact="infections" post="such as by CMV or by other immunological and"/>
  <result pre="as by CMV or by other immunological and environmental agents.7" exact="Severe" post="and life‐threatening hemorrhage is very rare (&amp;lt;1.0%) in such"/>
  <result pre="hemorrhage is very rare (&amp;lt;1.0%) in such cases.8, 9 CMV‐related" exact="secondary" post="ITP often occurs a few weeks after the onset"/>
  <result pre="often occurs a few weeks after the onset of CMV" exact="infection" post="symptoms such as fever, elevated liver enzymes, hepatosplenomegaly, and"/>
  <result pre="this period.3, 4 Meanwhile, CMV infects megakaryocytes directly, causing CMV" exact="infection" post="symptoms at the time of thrombocytopenia diagnosis. This mechanism"/>
  <result pre="megakaryocytes directly, causing CMV infection symptoms at the time of" exact="thrombocytopenia" post="diagnosis. This mechanism is regarded as CMV‐induced thrombocytopenia.3, 4"/>
  <result pre="as CMV‐induced thrombocytopenia.3, 4 It is difficult to distinguish CMV‐induced" exact="thrombocytopenia" post="from CMV‐related secondary ITP. However, early detection of CMV"/>
  <result pre="4 It is difficult to distinguish CMV‐induced thrombocytopenia from CMV‐related" exact="secondary" post="ITP. However, early detection of CMV infection is paramount"/>
  <result pre="thrombocytopenia from CMV‐related secondary ITP. However, early detection of CMV" exact="infection" post="is paramount because CMV‐induced thrombocytopenia occasionally requires antiviral therapy.3"/>
  <result pre="However, early detection of CMV infection is paramount because CMV‐induced" exact="thrombocytopenia" post="occasionally requires antiviral therapy.3 Herein, we report a case"/>
  <result pre="antiviral therapy.3 Herein, we report a case of refractory CMV‐induced" exact="thrombocytopenia" post="in a 38‐day‐old infant. 2 CLINICAL CASE REPORT A"/>
  <result pre="was admitted to our hospital because of the presence of" exact="petechiae" post="from trunk to legs and oral wet purpura. His"/>
  <result pre="with blood pressure of 98/60 mm Hg, pulse of 142/min," exact="respiratory" post="rate of 36/min, and O2 saturation of 100% on"/>
  <result pre="a white blood cell count of 23 600/µL with 11.0%" exact="atypical" post="lymphocytes, CD4‐positive cell count of 1044/µL, a hemoglobin level"/>
  <result pre="coagulation test was normal. His chest/abdominal CT findings were normal." exact="Platelet" post="transfusion was performed after admission because ITP was not"/>
  <result pre="cells and megakaryocyte count of 8/µL. After the exclusion of" exact="malignant" post="diseases, prednisolone (PSL; 1 mg/kg) was administered as a"/>
  <result pre="000/µL, but decreased to 18 000/µL after 2 days. CMV" exact="infection" post="was diagnosed based on the presence of CMV IgM"/>
  <result pre="increased to 2 mg/kg. Thereafter, his platelet count gradually normalized." exact="Thrombocytopenia" post="has not recurred after the discontinuation of PSL. The"/>
  <result pre="not in his dried umbilical cord. Based on these results," exact="thrombocytopenia" post="was associated with acquired CMV infection. No abnormalities were"/>
  <result pre="umbilical cord. Based on these results, thrombocytopenia was associated with" exact="acquired" post="CMV infection. No abnormalities were observed on brain magnetic"/>
  <result pre="patient was infected with CMV after birth, excluding a congenitally" exact="acquired" post="infection. Figure 1 Clinical course of our patient. IVIG,"/>
  <result pre="CMV‐induced thrombocytopenia. Our initial diagnosis was ITP. Retrospectively, however, CMV‐induced" exact="thrombocytopenia" post="is more suitable in the patient's diagnosis, because immune"/>
  <result pre="his age and the general peak occurrence of ITP in" exact="childhood" post="is between 2 and 5 years of age.10 In"/>
  <result pre="and 5 years of age.10 In a 38‐day‐old infant, either" exact="congenital" post="or acquired CMV infection can occur. Thrombocytopenia often occurs"/>
  <result pre="years of age.10 In a 38‐day‐old infant, either congenital or" exact="acquired" post="CMV infection can occur. Thrombocytopenia often occurs in patients"/>
  <result pre="age.10 In a 38‐day‐old infant, either congenital or acquired CMV" exact="infection" post="can occur. Thrombocytopenia often occurs in patients with congenital"/>
  <result pre="38‐day‐old infant, either congenital or acquired CMV infection can occur." exact="Thrombocytopenia" post="often occurs in patients with congenital CMV infection.11 In"/>
  <result pre="CMV infection can occur. Thrombocytopenia often occurs in patients with" exact="congenital" post="CMV infection.11 In our case, quantitative PCR did not"/>
  <result pre="reveal CMV‐DNA in his dried umbilical cord at birth,12 indicating" exact="acquired" post="CMV infection. The detection of CMV‐DNA in the dried"/>
  <result pre="CMV‐DNA in the dried umbilical cord is useful to prove" exact="congenital" post="CMV infection.13 In preterm babies, acquired CMV infection can"/>
  <result pre="is useful to prove congenital CMV infection.13 In preterm babies," exact="acquired" post="CMV infection can occur through breast milk because of"/>
  <result pre="to prove congenital CMV infection.13 In preterm babies, acquired CMV" exact="infection" post="can occur through breast milk because of the low"/>
  <result pre="infection.13 In preterm babies, acquired CMV infection can occur through" exact="breast" post="milk because of the low level of anti‐CMV antibodies"/>
  <result pre="transmitted via the placenta.14 Because the status of maternal CMV" exact="infection" post="was not evaluated, the infection route of CMV remained"/>
  <result pre="the status of maternal CMV infection was not evaluated, the" exact="infection" post="route of CMV remained to be determined in our"/>
  <result pre="remained to be determined in our case. CDC recommends that" exact="congenital" post="CMV infection should be diagnosed based on the presence"/>
  <result pre="be determined in our case. CDC recommends that congenital CMV" exact="infection" post="should be diagnosed based on the presence of CMV‐DNA"/>
  <result pre="the urine, saliva, or blood, within 3 weeks after birth." exact="Infection" post="cannot be diagnosed using tests that detect antibodies to"/>
  <result pre="be diagnosed using tests that detect antibodies to CMV.15 Moreover," exact="congenital" post="CMV infection cannot be diagnosed using samples collected more"/>
  <result pre="using tests that detect antibodies to CMV.15 Moreover, congenital CMV" exact="infection" post="cannot be diagnosed using samples collected more than three"/>
  <result pre="birth because testing after this time cannot distinguish between a" exact="congenital" post="infection and an infection acquired during or after delivery.15"/>
  <result pre="because testing after this time cannot distinguish between a congenital" exact="infection" post="and an infection acquired during or after delivery.15 In"/>
  <result pre="this time cannot distinguish between a congenital infection and an" exact="infection" post="acquired during or after delivery.15 In our case, we"/>
  <result pre="time cannot distinguish between a congenital infection and an infection" exact="acquired" post="during or after delivery.15 In our case, we could"/>
  <result pre="other samples within 3 weeks after his birth to detect" exact="congenital" post="CMV infection and the possibility of false‐negative results of"/>
  <result pre="within 3 weeks after his birth to detect congenital CMV" exact="infection" post="and the possibility of false‐negative results of CMV in"/>
  <result pre="thus be ruled out. Therefore, we could not rule out" exact="congenital" post="CMV infection completely. Thrombocytopenia in neonates is relatively common,"/>
  <result pre="ruled out. Therefore, we could not rule out congenital CMV" exact="infection" post="completely. Thrombocytopenia in neonates is relatively common, occurring in"/>
  <result pre="Therefore, we could not rule out congenital CMV infection completely." exact="Thrombocytopenia" post="in neonates is relatively common, occurring in 1%‐5% of"/>
  <result pre="and in 20%‐50% of sick infants. Frequent etiologies include sepsis," exact="disseminated intravascular coagulation," post="respiratory distress syndrome, and maternal factors, among others.16 Thrombocytopenia"/>
  <result pre="of sick infants. Frequent etiologies include sepsis, disseminated intravascular coagulation," exact="respiratory" post="distress syndrome, and maternal factors, among others.16 Thrombocytopenia due"/>
  <result pre="intravascular coagulation, respiratory distress syndrome, and maternal factors, among others.16" exact="Thrombocytopenia" post="due to maternal factors is caused by ITP, systemic"/>
  <result pre="others.16 Thrombocytopenia due to maternal factors is caused by ITP," exact="systemic" post="lupus erythematosus, and drugs.16 However, in our case, his"/>
  <result pre="Thrombocytopenia due to maternal factors is caused by ITP, systemic" exact="lupus erythematosus," post="and drugs.16 However, in our case, his mother showed"/>
  <result pre="normal. Therefore, we judged that there was no association between" exact="thrombocytopenia" post="and maternal causes in this case. Neonatal alloimmune thrombocytopenia"/>
  <result pre="no association between thrombocytopenia and maternal causes in this case." exact="Neonatal" post="alloimmune thrombocytopenia (NAIT) is the most common cause of"/>
  <result pre="between thrombocytopenia and maternal causes in this case. Neonatal alloimmune" exact="thrombocytopenia" post="(NAIT) is the most common cause of severe thrombocytopenia"/>
  <result pre="alloimmune thrombocytopenia (NAIT) is the most common cause of severe" exact="thrombocytopenia" post="in newborns.17 Typical patients with NAIT develop petechiae within"/>
  <result pre="of severe thrombocytopenia in newborns.17 Typical patients with NAIT develop" exact="petechiae" post="within minutes of birth, followed by ecchymosis and cephalohematoma.17"/>
  <result pre="of hemorrhage is in the first 96 hours of life." exact="Thrombocytopenia" post="in patients with NAIT resolves naturally within 1‐2 weeks"/>
  <result pre="perinatal period, we judged that there was no association between" exact="thrombocytopenia" post="and NAIT in this case, although anti‐human platelet antigen"/>
  <result pre="the retrospective analysis, there were no significant differences between CMV‐induced" exact="thrombocytopenia" post="and CMV‐related secondary ITP in terms of age, sex,"/>
  <result pre="there were no significant differences between CMV‐induced thrombocytopenia and CMV‐related" exact="secondary" post="ITP in terms of age, sex, and platelet count"/>
  <result pre="23 patients with CMV‐induced thrombocytopenia, while no patients with CMV‐related" exact="secondary" post="ITP required antiviral therapy. Furthermore, some patients with CMV‐induced"/>
  <result pre="secondary ITP required antiviral therapy. Furthermore, some patients with CMV‐induced" exact="thrombocytopenia" post="showed complicated clinical courses such as refractory or chronic"/>
  <result pre="with CMV‐induced thrombocytopenia showed complicated clinical courses such as refractory" exact="or chronic" post="courses, compared with CMV‐related secondary ITP. The data of"/>
  <result pre="CMV‐induced thrombocytopenia showed complicated clinical courses such as refractory or" exact="chronic" post="courses, compared with CMV‐related secondary ITP. The data of"/>
  <result pre="courses such as refractory or chronic courses, compared with CMV‐related" exact="secondary" post="ITP. The data of bone marrow examination did not"/>
  <result pre="bone marrow examination did not give new knowledge about CMV‐induced" exact="thrombocytopenia" post="and CMV‐related secondary ITP, because a few patients underwent"/>
  <result pre="did not give new knowledge about CMV‐induced thrombocytopenia and CMV‐related" exact="secondary" post="ITP, because a few patients underwent bone marrow examination."/>
  <result pre="conclusion, CMV should be evaluated in suspected cases of refractory" exact="thrombocytopenia" post="because CMV infection occasionally induces severe and refractory thrombocytopenia,"/>
  <result pre="be evaluated in suspected cases of refractory thrombocytopenia because CMV" exact="infection" post="occasionally induces severe and refractory thrombocytopenia, requiring antiviral therapy."/>
  <result pre="manuscript. References REFERENCES 1DiMaggioD, AndersonA, BusselJB. Cytomegalovirus can make immune" exact="thrombocytopenic purpura" post="refractory. Br J Haematol. 2009;146:104‐112.19438507 2ShimanovskyA, PatelD, WasserJ. Refractory"/>
  <result pre="References REFERENCES 1DiMaggioD, AndersonA, BusselJB. Cytomegalovirus can make immune thrombocytopenic" exact="purpura" post="refractory. Br J Haematol. 2009;146:104‐112.19438507 2ShimanovskyA, PatelD, WasserJ. Refractory"/>
  <result pre="thrombocytopenic purpura refractory. Br J Haematol. 2009;146:104‐112.19438507 2ShimanovskyA, PatelD, WasserJ." exact="Refractory" post="immune thrombocytopenic purpura and cytomegalovirus infection: a call for"/>
  <result pre="refractory. Br J Haematol. 2009;146:104‐112.19438507 2ShimanovskyA, PatelD, WasserJ. Refractory immune" exact="thrombocytopenic purpura" post="and cytomegalovirus infection: a call for a change in"/>
  <result pre="Br J Haematol. 2009;146:104‐112.19438507 2ShimanovskyA, PatelD, WasserJ. Refractory immune thrombocytopenic" exact="purpura" post="and cytomegalovirus infection: a call for a change in"/>
  <result pre="ChoiEM, et al. Clinical characteristics and treatment courses for cytomegalovirus‐associated" exact="thrombocytopenia" post="in immunocompetent children after neonatal period. Blood Res. 2018;53:110‐116.29963516"/>
  <result pre="and treatment courses for cytomegalovirus‐associated thrombocytopenia in immunocompetent children after" exact="neonatal" post="period. Blood Res. 2018;53:110‐116.29963516 4NishioY, KawanoY, KawadaJI, ItoY, HaraS."/>
  <result pre="courses for cytomegalovirus‐associated thrombocytopenia in immunocompetent children after neonatal period." exact="Blood" post="Res. 2018;53:110‐116.29963516 4NishioY, KawanoY, KawadaJI, ItoY, HaraS. A case"/>
  <result pre="4NishioY, KawanoY, KawadaJI, ItoY, HaraS. A case of refractory cytomegalovirus‐related" exact="thrombocytopenia" post="that achieved complete remission without antiviral therapy. J Infect"/>
  <result pre="ItoY, HaraS. A case of refractory cytomegalovirus‐related thrombocytopenia that achieved" exact="complete" post="remission without antiviral therapy. J Infect Chemother. 2018;24:995‐997.30001843 5SakataH,"/>
  <result pre="therapy. J Infect Chemother. 2018;24:995‐997.30001843 5SakataH, IkegamiK, NagayaK, ShiraiM, MaruyamaS." exact="Thrombocytopenia" post="caused by acquired cytomegalovirus infection in children. Pediatr Int."/>
  <result pre="Chemother. 2018;24:995‐997.30001843 5SakataH, IkegamiK, NagayaK, ShiraiM, MaruyamaS. Thrombocytopenia caused by" exact="acquired" post="cytomegalovirus infection in children. Pediatr Int. 1999;41:113‐114.10200150 6MizutaniK, AzumaE,"/>
  <result pre="2018;24:995‐997.30001843 5SakataH, IkegamiK, NagayaK, ShiraiM, MaruyamaS. Thrombocytopenia caused by acquired" exact="cytomegalovirus infection" post="in children. Pediatr Int. 1999;41:113‐114.10200150 6MizutaniK, AzumaE, KomadaY, et"/>
  <result pre="5SakataH, IkegamiK, NagayaK, ShiraiM, MaruyamaS. Thrombocytopenia caused by acquired cytomegalovirus" exact="infection" post="in children. Pediatr Int. 1999;41:113‐114.10200150 6MizutaniK, AzumaE, KomadaY, et"/>
  <result pre="children. Pediatr Int. 1999;41:113‐114.10200150 6MizutaniK, AzumaE, KomadaY, et al. An" exact="infantile" post="case of cytomegalovirus induced idiopathic thrombocytopenic purpura with predominant"/>
  <result pre="AzumaE, KomadaY, et al. An infantile case of cytomegalovirus induced" exact="idiopathic thrombocytopenic purpura" post="with predominant proliferation of CD10 positive lymphoblast in bone"/>
  <result pre="KomadaY, et al. An infantile case of cytomegalovirus induced idiopathic" exact="thrombocytopenic purpura" post="with predominant proliferation of CD10 positive lymphoblast in bone"/>
  <result pre="et al. An infantile case of cytomegalovirus induced idiopathic thrombocytopenic" exact="purpura" post="with predominant proliferation of CD10 positive lymphoblast in bone"/>
  <result pre="al. International consensus report on the investigation and management of" exact="primary" post="immune thrombocytopenia. Blood. 2010;115:1668‐1686. 8ImbachP, KühneT, MüllerD, et al."/>
  <result pre="primary immune thrombocytopenia. Blood. 2010;115:1668‐1686. 8ImbachP, KühneT, MüllerD, et al." exact="Childhood" post="ITP: 12 months follow‐up data from the prospective registry"/>
  <result pre="follow‐up data from the prospective registry I of the Intercontinental" exact="Childhood" post="ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46:351‐356.16086422 9ButrosLJ,"/>
  <result pre="I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr" exact="Blood" post="Cancer. 2006;46:351‐356.16086422 9ButrosLJ, BusselJB. Intracranial hemorrhage in immune thrombocytopenic"/>
  <result pre="Pediatr Blood Cancer. 2006;46:351‐356.16086422 9ButrosLJ, BusselJB. Intracranial hemorrhage in immune" exact="thrombocytopenic" post="purpura: a retrospective analysis. J Pediatr Hematol Oncol. 2003;25:660‐664.12902925"/>
  <result pre="comparative study of 2540 infants and children with newly diagnosed" exact="idiopathic thrombocytopenic purpura" post="(ITP) from the Intercontinental Childhood ITP Study Group. J"/>
  <result pre="study of 2540 infants and children with newly diagnosed idiopathic" exact="thrombocytopenic purpura" post="(ITP) from the Intercontinental Childhood ITP Study Group. J"/>
  <result pre="of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic" exact="purpura" post="(ITP) from the Intercontinental Childhood ITP Study Group. J"/>
  <result pre="with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental" exact="Childhood" post="ITP Study Group. J Pediatr. 2003;143:605‐608.14615730 11KylatRI, KellyEN, Ford‐JonesEL."/>
  <result pre="KellyEN, Ford‐JonesEL. Clinical findings and adverse outcome in neonates with" exact="symptomatic" post="congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr. 2006;165:773‐778.16835757 12WatzingerF,"/>
  <result pre="Ford‐JonesEL. Clinical findings and adverse outcome in neonates with symptomatic" exact="congenital" post="cytomegalovirus (SCCMV) infection. Eur J Pediatr. 2006;165:773‐778.16835757 12WatzingerF, SudaM,"/>
  <result pre="Microbiol. 2004;42:5189‐5198.15528714 13KoyanoS, ArakiA, HiranoY, et al. Retrospective diagnosis of" exact="congenital" post="cytomegalovirus infection using dried umbilical cords. Pediatr Infect Dis"/>
  <result pre="2004;42:5189‐5198.15528714 13KoyanoS, ArakiA, HiranoY, et al. Retrospective diagnosis of congenital" exact="cytomegalovirus infection" post="using dried umbilical cords. Pediatr Infect Dis J. 2004;23:481‐482.15131484"/>
  <result pre="13KoyanoS, ArakiA, HiranoY, et al. Retrospective diagnosis of congenital cytomegalovirus" exact="infection" post="using dried umbilical cords. Pediatr Infect Dis J. 2004;23:481‐482.15131484"/>
  <result pre="Pediatr Infect Dis J. 2004;23:481‐482.15131484 14LanzieriTM, DollardSC, JosephsonCD, SchmidDS, BialekSR." exact="Breast" post="milk‐acquired cytomegalovirus infection and disease in VLBW and premature"/>
  <result pre="Dis J. 2004;23:481‐482.15131484 14LanzieriTM, DollardSC, JosephsonCD, SchmidDS, BialekSR. Breast milk‐acquired" exact="cytomegalovirus infection" post="and disease in VLBW and premature infants. Pediatrics. 2013;131:e1937‐e1945.23713111"/>
  <result pre="J. 2004;23:481‐482.15131484 14LanzieriTM, DollardSC, JosephsonCD, SchmidDS, BialekSR. Breast milk‐acquired cytomegalovirus" exact="infection" post="and disease in VLBW and premature infants. Pediatrics. 2013;131:e1937‐e1945.23713111"/>
  <result pre="14LanzieriTM, DollardSC, JosephsonCD, SchmidDS, BialekSR. Breast milk‐acquired cytomegalovirus infection and" exact="disease" post="in VLBW and premature infants. Pediatrics. 2013;131:e1937‐e1945.23713111 15collab: Centers"/>
  <result pre="in VLBW and premature infants. Pediatrics. 2013;131:e1937‐e1945.23713111 15collab: Centers for" exact="Disease" post="Control and Prevention .Cytomegalovirus (CMV) and congenital CMV infection."/>
  <result pre="15collab: Centers for Disease Control and Prevention .Cytomegalovirus (CMV) and" exact="congenital" post="CMV infection. 2019https://www.cdc.gov/cmv/clinical/lab-tests.html. Accessed November 27, 2019. 16ChakravortyS, RobertsI."/>
  <result pre="2019https://www.cdc.gov/cmv/clinical/lab-tests.html. Accessed November 27, 2019. 16ChakravortyS, RobertsI. How I manage" exact="neonatal" post="thrombocytopenia. Br J Haematol. 2012;156:155‐162.21950766 17BakchoulT, BasslerD, HeckmannM, et"/>
  <result pre="BasslerD, HeckmannM, et al. Management of infants born with severe" exact="neonatal" post="alloimmune thrombocytopenia: the role of platelet transfusions and intravenous"/>
 </snippets>
</snippetsTree>
